marijuana stocks news

Form 8-K for ENERTOPIA CORP.

20-Oct-2014

Change in Directors or Principal Officers, Regulation FD Disclosure, Financial St

Item 5.02 Departure of DirectorsAs previously disclosed, our company had entered into a Joint Venture Agreement (the “WOM Agreement”) on January 16, 2014 with World of Marihuana Productions Ltd. (“WOM”) whereby our company could acquire up to a 51% interest in the Joint Venture business described therein. WOM had applied to acquire a license issued by Health Canada (the “License”) to allow for WOM to operate a business of legally producing, manufacturing, propagating, importing/exporting, testing, researching and developing, and selling marijuana (the “Business”).

On October 16, 2014 we entered into a termination and settlement agreement, dated effective October 14, 2014, with WOM and Mathew Chadwick (the “Settlement Agreement”), pursuant to which the parties have entered into mutual releases, Mr. Chadwick has resigned from our board of directors and as an officer of the company, and WOM has returned back to the treasury of the company 15,127,287 common shares that had been issued to it. Given the foregoing, all relationships between the parties, including but not limited to the WOM Agreement in regards to the Joint Venture business, have been terminated.

Item 7.01 Regulation FD DisclosureA copy of the news release announcing the Settlement Agreement is filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

Item 9.01 Financial Statements and Exhibits10.1 Termination and Settlement Agreement with 0786521 B.C. Ltd (formerly World of Marihuana Productions Ltd.) and Mathew Chadwick

99.1 News release dated October 17, 2014

Source: https://biz.yahoo.com/e/141020/enrt8-k.html


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$GWPH Initiates Second Phase 3 Pivotal Trial for Epidiolex in Dravet Syndrome

GW Pharmaceuticals Initiates Second Phase 3 Pivotal Trial for Epidiolex in Dravet…

AbbVie Inc. (ABBV) to Host Second-Quarter 2022 Earnings Conference Call

AbbVie to Host Second-Quarter 2022 Earnings Conference Call AbbVie (NYSE: ABBV) will…

Canopy Growth Corporation (WEED.TO) (CGC) announces shareholder approval in connection with the proposed acquisition of Acreage

Canopy Growth announces shareholder approval in connection with the proposed acquisition of…

$OGRMF Income Statement

OrganiGram Holdings Inc. (OGRMF)     Income Statement Get Income Statement for:…